Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
JAMA Network Open
|
August 6, 2024
Outcomes and Mechanisms Associated With Selective Thalamic Neuronal Loss in Chronic Traumatic Brain Injury
Rebecca E Woodrow, Julia Grossac, Young T Hong, et al.
Brain : a Journal of Neurology
|
October 29, 2013
A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment
Natalia del Campo, Tim D Fryer, Young T Hong, et al.
Brain Communications
|
December 19, 2025
Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy
Noah L Shapiro, Peter Simon Jones, Elijah Mak, et al.
Neurobiology of Aging
|
February 25, 2021
In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies
Elijah Mak, Negin Holland, P Simon Jones, et al.
Annals of Clinical and Translational Neurology
|
January 19, 2017
[<sup>18</sup>F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation
W Richard Bevan Jones, Thomas E Cope, Luca Passamonti, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 7, 2022
Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
Concepcion Padilla, Victor Montal, Madeleine J Walpert, et al.
Neurology
|
April 29, 2018
[<sup>11</sup>C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
Luca Passamonti, Patricia Vázquez Rodríguez, Young T Hong, et al.
Nature Communications
|
December 19, 2023
Synaptic density affects clinical severity via network dysfunction in syndromes associated with frontotemporal lobar degeneration
David J Whiteside, Negin Holland, Kamen A Tsvetanov, et al.
Brain : a Journal of Neurology
|
March 18, 2020
Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum
W Richard Bevan-Jones, Thomas E Cope, P Simon Jones, et al.
The Lancet. Neurology
|
December 13, 2025
Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
Julia C Greenland, Kerry Dresser, Emma Cutting, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
JAMA Network Open
|
August 6, 2024
Outcomes and Mechanisms Associated With Selective Thalamic Neuronal Loss in Chronic Traumatic Brain Injury
Rebecca E Woodrow, Julia Grossac, Young T Hong, et al.
Brain : a Journal of Neurology
|
October 29, 2013
A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment
Natalia del Campo, Tim D Fryer, Young T Hong, et al.
Brain Communications
|
December 19, 2025
Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy
Noah L Shapiro, Peter Simon Jones, Elijah Mak, et al.
Neurobiology of Aging
|
February 25, 2021
In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies
Elijah Mak, Negin Holland, P Simon Jones, et al.
Annals of Clinical and Translational Neurology
|
January 19, 2017
[<sup>18</sup>F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation
W Richard Bevan Jones, Thomas E Cope, Luca Passamonti, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 7, 2022
Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
Concepcion Padilla, Victor Montal, Madeleine J Walpert, et al.
Neurology
|
April 29, 2018
[<sup>11</sup>C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
Luca Passamonti, Patricia Vázquez Rodríguez, Young T Hong, et al.
Nature Communications
|
December 19, 2023
Synaptic density affects clinical severity via network dysfunction in syndromes associated with frontotemporal lobar degeneration
David J Whiteside, Negin Holland, Kamen A Tsvetanov, et al.
Brain : a Journal of Neurology
|
March 18, 2020
Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum
W Richard Bevan-Jones, Thomas E Cope, P Simon Jones, et al.
The Lancet. Neurology
|
December 13, 2025
Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
Julia C Greenland, Kerry Dresser, Emma Cutting, et al.
Page
of 10